Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Vasella adds voice to NHS criticism

August 27, 2009 Research and Development, Sales and Marketing NHS, healthcare

Novartis chief executive Daniel Vasella defended the industry's high cost oncology treatments, and said he would not want to be …
News

Gardasil cleared in FDA safety review

August 27, 2009 Research and Development, Sales and Marketing Gardasil, US, vaccines

News

Warner Chilcott buys P&G pharma for $3.1 billion

August 25, 2009 Research and Development, Sales and Marketing MA, P&G, Warner Chilcott

Specialist pharma company Warner Chilcott is to buy Procter & Gamble's pharmaceutical division for $3.1 billion, turning it into a …
News

Pfizer to develop online community to find new trials patients

August 24, 2009 Medical Communications, Research and Development, Sales and Marketing Pfizer, digi

Pfizer is hoping to unlock the power of online communities to help it recruit more people for clinical trials.Pfizer has …
News

‘No shortcuts’ on H1N1 vaccine safety says GlaxoSmithKline

August 20, 2009 Research and Development, Sales and Marketing GSK, h1n1, vaccines

GlaxoSmithKline says the public need not doubt the safety of its vaccine against the H1N1 swine flu, which it is …
News

Avastin shows promise in advanced breast cancer

August 20, 2009 Research and Development, Sales and Marketing Roche, avastin, breast cancer

Avastin's rise continues as new data suggests it improves progression-free survival as a second line treatment for advanced breast cancer.The …
News

Obstacles remain for patients with blood cancers

August 20, 2009 Research and Development, Sales and Marketing NICE, blood cancer

News

Manchester research hub appoints industry liaison

August 19, 2009 Research and Development Academic, NHS

The Manchester Biomedical Research Centre (BRC) has appointed a new industry-facing executive to forge new research links with the industry.Dr …
News

Novartis’ Extavia approved in US

August 19, 2009 Research and Development, Sales and Marketing Extavia, MS, Novartis

 Novartis has received US approval for its betaferon product for multiple sclerosis.Extavia’s active ingredient is interferon beta-1b, putting it into …
News

US pharma accused of selling out to Obama

August 19, 2009 Research and Development, Sales and Marketing US, US healthcare, healthcare, industry

The US industry is accused of selling out to President Obama’s healthcare take-over, with its leaders seeking favourable treatment from …
News

Off-label rules for cancer need to be clarified

August 18, 2009 Research and Development, Sales and Marketing Cancer, NHS, off label

A new report is pressing for the off label prescribing of drugs to be made clearer and more fair for …
News

ClinPhone accounts give Parexel a hangover

August 18, 2009 Research and Development Clinphone

Accounting errors at recently-acquired ClinPhone pegged back Parexel's operating profits in its latest quarterly reports, and it will be some …
News

GSK starts first trials for H1N1 vaccine in Germany

August 17, 2009 Research and Development, Sales and Marketing GSK, h1n1, vaccines

GSK is to embark on the clinical development for its pandemic swine flu vaccine, completing enrolment into its first study …
News

Genzyme says Cerezyme shortages could last longer than expected

August 17, 2009 Research and Development, Sales and Marketing Gaucher, Genzyme

The shortage of Genzyme's enzyme replacement therapy Cerezyme look set to last longer than expected, as the company has taken …
News

Vulnerable groups first in line for UK swine flu jabs

August 14, 2009 Research and Development, Sales and Marketing NHS, h1n1

The first 11 million people to receive jabs against the H1N1 virus have been announced by the government, ready for …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025